Establishment Labs Holdings Inc. (ESTA) stock
ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$70.80+1.29 (+1.86%)
Close on Nov 18, 2026Market cap $2.11BP/E –Yield –
Establishment Labs operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Establishment Labs's operating income for the twelve months ending Sep 30, 2026 was -$17.35M. For fiscal 2025 it was -$39.01M. The highest annual figure on record is -$19.98M in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$39.01M | – |
| FY2024 | Dec 31, 2024 | -$49.99M | – |
| FY2023 | Dec 31, 2023 | -$65.03M | – |
| FY2022 | Dec 31, 2022 | -$39.66M | – |
| FY2021 | Dec 31, 2021 | -$25.14M | – |
| FY2020 | Dec 31, 2020 | -$27.92M | – |
| FY2019 | Dec 31, 2019 | -$30.94M | – |
| FY2018 | Dec 31, 2018 | -$23.86M | – |
| FY2017 | Dec 31, 2017 | -$19.98M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.62M | – |
| Q2 FY2026 | Jun 30, 2026 | -$4.29M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.51M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.03M | – |
| Q2 FY2025 | Jun 30, 2025 | -$14.11M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.67M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.14M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.34M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.83M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.12M | – |
| Q3 FY2023 | Sep 30, 2023 | -$21.04M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.71M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.16M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.16M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.52M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.41M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.58M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.37M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.04M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.63M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.10M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.02M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.59M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.60M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.71M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.41M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.77M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.38M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.39M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.62M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.05M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.32M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.88M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.59M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.97M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.48M | – |
See a number that looks wrong?